← Map · Health Care Equipment · S&P SmallCap 600
LMAT LEMAITRE VASCULAR $1.8B
No. The only AI sentence is a European law.
1 of 15
Reach, Weight, and Proof.
0Reach
0Weight
1Proof
What they are doing
LeMaitre's 10-K does not describe an AI product or an AI use in the vascular business. The phrase appears once, as the EU Artificial Intelligence Act, a compliance cost with a rolling start in 2025.
Why the score
- Reach 0 not 1: complying with a law is not a function on the chain.
- Weight 0 not 1: no experiment.
- Proof 1 not 0: the Act is named.
- Proof 1 not 2: not tied to an operating use.
What would move it next quarter: A named intelligence layer in a vascular product. Another compliance paragraph will not move this.
Open these first
2025 10-KNames the EU AI Act as a cost, not a product.
Evidence
2025 Form 10-K
In 2023, Europe finalized the first comprehensive legal framework for governance of the use of artificial intelligence, the EU Artificial Intelligence Act, with a rolling effective date that commenced in 2025. Compliance has caused and will cause additional costs.